SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $81,049 | -26.1% | 62,345 | 0.0% | 0.00% | – |
| Q1 2023 | $109,727 | -43.9% | 62,345 | 0.0% | 0.00% | – |
| Q4 2022 | $195,763 | -36.0% | 62,345 | -0.2% | 0.00% | -100.0% |
| Q3 2022 | $306,000 | +18.1% | 62,455 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $259,000 | -28.7% | 62,455 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $363,000 | -48.2% | 62,445 | -33.2% | 0.00% | 0.0% |
| Q4 2021 | $701,000 | +26.1% | 93,532 | +51.6% | 0.00% | 0.0% |
| Q3 2021 | $556,000 | -24.8% | 61,708 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $739,000 | +8.5% | 61,708 | +13.5% | 0.00% | 0.0% |
| Q1 2021 | $681,000 | -25.2% | 54,375 | -6.8% | 0.00% | -50.0% |
| Q4 2020 | $910,000 | +65.2% | 58,315 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $551,000 | +5.4% | 58,315 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $523,000 | +41.0% | 58,315 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $371,000 | -24.0% | 58,315 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $488,000 | -7.6% | 58,315 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $528,000 | -15.9% | 58,315 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $628,000 | +13.2% | 58,315 | +0.3% | 0.00% | +100.0% |
| Q1 2019 | $555,000 | -16.9% | 58,145 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $668,000 | -32.3% | 58,145 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $986,000 | +19.4% | 58,145 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $826,000 | -24.9% | 58,145 | +0.4% | 0.00% | -33.3% |
| Q1 2018 | $1,100,000 | +9.8% | 57,895 | -5.2% | 0.00% | 0.0% |
| Q4 2017 | $1,002,000 | +9.4% | 61,070 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $916,000 | +70.6% | 61,070 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $537,000 | +68.9% | 61,070 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $318,000 | +71.0% | 61,070 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $186,000 | -34.3% | 61,070 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $283,000 | -20.1% | 61,070 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $354,000 | -4.1% | 61,070 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $369,000 | -33.9% | 61,070 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $558,000 | +62.2% | 61,070 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $344,000 | -49.0% | 61,070 | +0.3% | 0.00% | -50.0% |
| Q2 2015 | $675,000 | -29.3% | 60,910 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $955,000 | -2.2% | 60,910 | -5.1% | 0.00% | 0.0% |
| Q4 2014 | $976,000 | +41.2% | 64,200 | +0.2% | 0.00% | +50.0% |
| Q3 2014 | $691,000 | -29.3% | 64,065 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $978,000 | -11.2% | 64,065 | +5.2% | 0.00% | -25.0% |
| Q1 2014 | $1,101,000 | +30.1% | 60,919 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $846,000 | +32.6% | 60,919 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $638,000 | +34.0% | 60,919 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $476,000 | – | 60,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |